You searched for Antibody candidate - Page 39 of 69

More News! 29 Sep 2022

Positive results from Eisai and Biogen Alzheimer’s trial

…antibody. It met the primary endpoint and all key secondary endpoints with highly statistically significant results. Lecanemab is an investigational humanized monoclonal antibody for AD that is the result of…

September 29, 2022 - 6 minutesmins - By Jim Cornall

In Depth 5 Feb 2024

Future of cancer treatment: what will therapy look like in 2034?

…the clinic. Maher expects antibody-based therapeutics to continue to yield new drugs like immunomodulatory agents and antibody drug conjugates “that deliver ever more powerful poisons in a selective manner to…

February 5, 2024 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 19 Nov 2016

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

…therapeutic antibody’s development due to the similarity of the cells to human cells (e.g. folding, glycosylation etc). For example, CHO-K1-based cell lines, derived from the ovarian cells of the Chinese…

November 19, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 17 Jun 2022

ImCheck raises €96M in funding round

…The Marseille-based company hopes it will reach a wider range of cancer immunotherapy with the antibody drugs that include a lead candidate in the development for liquid and solid tumors. …

June 17, 2022 - 3 minutesmins - By Liza Laws

Interview 14 Nov 2022

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

…long-acting antibody designed for all infants for protection against RSV disease from birth through their first RSV season with a single dose, is being developed jointly by AstraZeneca and Sanofi…

November 14, 2022 - 9 minutesmins - By Jim Cornall

In Depth 15 Feb 2024

Turning the tide: recent advancements in childhood cancer research

…the formation of a tumor. As neuroblastomas predominantly express the molecule GD2, Renaissance’s lead candidate Hu14.18 is a humanized, anti-GD2 antibody. When an anti-GD2 antibody is combined with chemotherapy in…

February 15, 2024 - 8 minutesmins - By Roohi Mariam Peter

sanofi genzyme antibodies geel pompe leukemia

News and Trends 29 Apr 2016

Big Pharma invest massively in Biomanufacturing facilities

…which represents a good chunk of Sanofi Genzyme – 10 of the 46 candidates currently in development. The pipeline of Sanofi Genzyme, with antibody therapies highlighted in green (Source: Sanofi…

April 29, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 5 Mar 2018

Danish Biotech Starts Phase III Atopic Dermatitis Trial With Failed Asthma Treatment

Danish biotech LEO Pharma started a Phase III trial in atopic dermatitis with an antibody that AstraZeneca dropped after failing two Phase III trials in asthma. LEO Pharma is taking…

March 5, 2018 - 2 minutesmins - By Alexander Burik

Best in Biotech 22 Dec 2021

The Biggest European Biotech News of 2021

…to be absorbed into the US firm Enbiotix after disappointing results from drug candidates for bacterial infections and cancer. Meanwhile, fresh waves of Covid-19 dog efforts to return to normality….

December 22, 2021 - 10 minutesmins - By Jonathan Smith

News and Trends 12 Oct 2022

Novavax COVID-19 vaccine data supports homologous and heterologous boosting

…a type of antibody) levels increased significantly relative to pre-boost levels, rising above the level correlated with 95% vaccine efficacy in a recent USG study. Neutralizing antibodies against the prototype…

October 12, 2022 - 3 minutesmins - By Liza Laws

Patrick Baeuerle Successful German Biotech Leader

Interview 17 Apr 2017

Meet One of the Most Successful German Biotech Leaders Ever

…looked like a disaster in the first place, created the opportunity to develop a bispecific T cell-engaging antibody that was in-licensed from inventors at Munich’s LMU. This antibody ultimately became…

April 17, 2017 - 6 minutesmins - By Philip Hemme

probiodrug alzheimers disease mechanism of action

News and Trends 30 Aug 2017

German Scientists Publish New Mechanism of Action Against Alzheimer’s

…developing a therapeutic antibody with a unique mode of action against Alzheimer’s, PBD-C06. The company announced yesterday the publication in the Journal of Biological Chemistry of the detailed binding mechanism…

August 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Positive results from Eisai and Biogen Alzheimer’s trial

Future of cancer treatment: what will therapy look like in 2034?

Looking for outperforming cell lines ? CHOvolution is an all-in-one kit for GMP Bioproduction

ImCheck raises €96M in funding round

In depth interview: AstraZeneca/Sanofi RSV drug Beyfortus

Turning the tide: recent advancements in childhood cancer research

Big Pharma invest massively in Biomanufacturing facilities

Danish Biotech Starts Phase III Atopic Dermatitis Trial With Failed Asthma Treatment

The Biggest European Biotech News of 2021

Novavax COVID-19 vaccine data supports homologous and heterologous boosting

Meet One of the Most Successful German Biotech Leaders Ever

German Scientists Publish New Mechanism of Action Against Alzheimer’s

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!